Epinephrine Autoinjectors: Fixed-Dose Device Requirements for Emergency Use
Published 2026-10-27 · Keywords: epinephrine auto injector
An epinephrine autoinjector is the most unforgiving device brief in the category: one fixed dose, an untrained user, a life-critical administration window, and intramuscular delivery that has to work the first time. The UrgoPen platform is built around exactly that brief — a custom 2.25 mL cartridge, fill volume 0.15–2.0 mL, minimum deliverable 0.15 mL, maximum dose 2.0 mL, with a dose window wide enough for intramuscular delivery.
What “emergency-grade” means in device terms
| Requirement | Why emergency use sets it | UrgoPen response |
|---|---|---|
| One-action simplicity | Untrained or panicking user; no dial, no dose-setting steps | Fixed-dose architecture — the dose is the fill |
| Reliable activation | First-time administration must complete | Simple two-step activation workflow |
| Adequate delivery window | Intramuscular epinephrine dosing needs volume headroom | Custom 2.25 mL cartridge; fill 0.15–2.0 mL; max 2.0 mL |
| Mature, low-complaint design | Complaint rates on emergency devices draw regulatory scrutiny | Mature design with a stated pen lifetime of 3 years |
| Availability | Programs cannot wait a full tooling cycle | Off-the-shelf devices available within weeks |
The fixed-dose architecture is the safety feature: nothing for the user to set, nothing to mis-set. Every design decision that removes a user step removes a human-factors risk from your file.
The program questions specific to this category
Fill and dose confirmation. Your target dose strength determines the fill within the 0.15–2.0 mL window; the device delivers the fill, so label strength and fill specification must be locked together. Customization for market identity. UrgoPen accepts custom colours on cap and housing plus logo/trademark printing — brand distinction matters in emergency categories where users must recognize their device instantly. Documentation set. Emergency categories attract the strictest review of use-condition evidence; request the full test report list per ISO 11608 part early.
How to verify a supplier in this category
Three checks: the controlled specification sheet with the stated pen lifetime, the functional test reports for activation and delivery, and — because emergency programs often launch in multiple markets — the certificate scope (ISO 13485 scope text, MDSAP evidence) covering your target regulators, with the copies released once an order is in place.
What this does not cover
The device ships empty and contains no drug; “epinephrine” here is the intended application example, not a therapeutic claim. Dose strength selection and clinical guidelines belong to your medical and regulatory teams.
Next step: send your dose strength and target markets — we return the UrgoPen configuration, its documentation set and availability inside one working day. Start the inquiry.
Related reading
Talk to NOVIXPEN about your program
Send your container format, annual volume and target market — we reply with the platform match, documentation set and written quotation within one working day.
Start the inquiry